COVID-19 in pregnancy

© Royal College of Physicians 2021. All rights reserved..

Pregnant women with COVID-19 are less likely to be symptomatic than non-pregnant counterparts. Risk factors for severe disease include being overweight or obese, greater than 35 years old, and having pre-existing comorbidities. Those who develop severe disease have increased rates of admission to an intensive care unit, requiring invasive ventilation and pre-term birth.Pregnant and breastfeeding women with COVID-19 should be investigated as of outside pregnancy and should receive proven therapies (such as corticosteroids and tocilizumab) on a risk/benefit basis. Admitted women should receive multidisciplinary care with input from senior decision makers and early escalation where required. There are no safety concerns -surrounding the COVID-19 vaccination and fertility or pregnancy, and so it should be offered to women based on their age and clinical risk group, in line with non-pregnant women.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Clinical medicine (London, England) - Vol. 21, No. 5 (2021), p. e446-e450

Language:

English

Contributors:

Nana, Melanie
Nelson-Piercy, Catherine

Links:

Volltext

Keywords:

*COVID-19
*Pregnancy Complications, Infectious
Adult
COVID-19
COVID-19 Vaccines
Female
Humans
Journal Article
Maternal outcomes
Multidisciplinary care
Pregnancy
Risk Factors
SARS-CoV-2
Vaccination

Notes:

Date Completed 16.09.2021

Date Revised 18.09.2021

published: Print

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.7861/clinmed.2021-0503

PMID:

34507928

PPN (Catalogue-ID):

NLM331696479